Global Paclitaxel Market Expected to Witness a Sustainable Growth over 2025 – QY Research

QYRlogo

 

 

This report studies the Paclitaxel market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

 

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it “taxol”.

 

Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.

 

The report is revolving around Paclitaxel active pharmaceutical ingredients.

 

In the last several years, global market of Paclitaxel developed rapidly, with an average growth rate of 12.3%. In 2017, global revenue of Paclitaxel is nearly 80 M USD; the actual production is about 2600 Kg.

The classification of Paclitaxel includes Natural Paclitaxel API and Semi-synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.

Paclitaxel is widely sales for Ovarian Cancer, Cervical Cancer, Breast Cancer and Others. The most proportion of Paclitaxel is sales in Ovarian Cancer, and the consumption proportion is about 46% in 2017.

The global Paclitaxel market was xx million US$ in 2017 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2018 and 2025.

 

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The leading players include following list:

Phyton

ScinoPharm

Novasep

Samyang

Polymed

TAPI (Teva)

Fresenius-kabi

Huiang biopharma

Southpharma

Yunnan Hande

Hainan Yew Pharm

Jiangsu Yew Biotechnology

 

We can also provide the customized separate regional or country-level reports, for the following regions:

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Rest of Asia-Pacific

Europe

Germany

France

UK

Italy

Spain

Russia

Rest of Europe

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

Rest of Middle East & Africa

 

 

 

Request Sample Report and TOC@ https://www.qyresearch.com/index/detail/332297/global-paclitaxel-market 

 

About Us: QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

 

 

Contact US

 

QY Research, INC.

 

17890 Castleton, Suite 218,

 

City of industry, CA – 91748

 

USA: +1 626 295 2442

 

Email: global@qyrsearch.com

 

Web: www.qyresearch.com

 

For other region, contact number given below

 

+86 108 294 5717 Beijing

 

+81 903 800 9273 Japan

 

+91 114 046 9822 India

 

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s